Endolysosome involvement in HIV-1 transactivator protein-induced neuronal amyloid beta production

Neurobiology of Aging

Volumn 34, Issue 10, 2013, Pages 2370-2378

  Chen, Xuesong ^a   Hui, Liang ^a   Geiger, Nicholas H ^a   Haughey, Norman J ^b   Geiger, Jonathan D ^a  

^a UNIVERSITY OF NORTH DAKOTA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amyloid beta; BACE 1; Endolysosome; HIV 1 Tat; pH

Indexed keywords

AMYLOID BETA PROTEIN; BETA SECRETASE; TRANSACTIVATOR PROTEIN; TRANSACTIVATOR PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CELL PH; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYO; ENDOLYSOSOME; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOHISTOCHEMISTRY; LYSOSOME; NONHUMAN; PRIORITY JOURNAL; RAT;

AMYLOID BETA; BACE-1; ENDOLYSOSOME; HIV-1 TAT; PH;

AIDS DEMENTIA COMPLEX; AMYLOID BETA-PEPTIDES; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; CELLS, CULTURED; FEMALE; HIPPOCAMPUS; HIV-1; HUMANS; HYDROGEN-ION CONCENTRATION; LYSOSOMES; NEURONS; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; REV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84879885541     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.04.015     Document Type: Article

References (72)

1. Achim C.L., Adame A., Dumaop W., Everall I.P., Masliah E. Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. J.Neuroimmune Pharmacol. 2009, 4:190-199.
2. Agrawal L., Louboutin J.P., Reyes B.A., Van Bockstaele E.J., Strayer D.S. HIV-1 Tat neurotoxicity: a model of acute and chronic exposure, and neuroprotection by gene delivery of antioxidant enzymes. Neurobiol. Dis. 2012, 45:657-670.
3. Aksenov M.Y., Aksenova M.V., Mactutus C.F., Booze R.M. Attenuated neurotoxicity of the transactivation-defective HIV-1 Tat protein in hippocampal cell cultures. Exp. Neurol. 2009, 219:586-590.
4. Aksenov M.Y., Aksenova M.V., Mactutus C.F., Booze R.M. HIV-1 protein-mediated amyloidogenesis in rat hippocampal cell cultures. Neurosci. Lett. 2010, 475:174-178.
5. Almeida C.G., Takahashi R.H., Gouras G.K. Beta-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system. J.Neurosci. 2006, 26:4277-4288.
6. Arriagada C., Astorga C., Atwater I., Rojas E., Mears D., Caviedes R., Caviedes P. Endosomal abnormalities related to amyloid precursor protein in cholesterol treated cerebral cortex neuronal cells derived from trisomy 16 mice, an animal model of Down syndrome. Neurosci. Lett. 2007, 423:172-177.
7. Banks W.A., Robinson S.M., Nath A. Permeability of the blood-brain barrier to HIV-1 Tat. Exp. Neurol. 2005, 193:218-227.
8. Boland B., Kumar A., Lee S., Platt F.M., Wegiel J., Yu W.H., Nixon R.A. Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. J.Neurosci. 2008, 28:6926-6937.
9. Buscemi L., Ramonet D., Geiger J.D. Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity. Neurobiol. Dis. 2007, 26:661-670.
10. Caron N.J., Quenneville S.P., Tremblay J.P. Endosome disruption enhances the functional nuclear delivery of Tat-fusion proteins. Biochem. Biophys. Res. Commun. 2004, 319:12-20.
11. Cataldo A.M., Petanceska S., Terio N.B., Peterhoff C.M., Durham R., Mercken M., Mehta P.D., Buxbaum J., Haroutunian V., Nixon R.A. Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome. Neurobiol. Aging 2004, 25:1263-1272.
12. Cataldo A.M., Peterhoff C.M., Troncoso J.C., Gomez-Isla T., Hyman B.T., Nixon R.A. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am. J. Pathol. 2000, 157:277-286.
13. Chyung J.H., Selkoe D.J. Inhibition of receptor-mediated endocytosis demonstrates generation of amyloid beta-protein at the cell surface. J.Biol. Chem. 2003, 278:51035-51043.
14. Clifford D.B., Fagan A.M., Holtzman D.M., Morris J.C., Teshome M., Shah A.R., Kauwe J.S. CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease. Neurology 2009, 73:1982-1987.
15. Deshmane S.L., Mukerjee R., Fan S., Sawaya B.E. High-performance capillary electrophoresis for determining HIV-1 Tat protein in neurons. PLoS One 2011, 6:e16148.
16. Drin G., Cottin S., Blanc E., Rees A.R., Temsamani J. Studies on the internalization mechanism of cationic cell-penetrating peptides. J.Biol. Chem. 2003, 278:31192-31201.
17. Ellis R.J., Gamst A.C., Capparelli E., Spector S.A., Hsia K., Wolfson T., Abramson I., Grant I., McCutchan J.A. Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology 2000, 54:927-936.
18. Ellis R.J., Rosario D., Clifford D.B., McArthur J.C., Simpson D., Alexander T., Gelman B.B., Vaida F., Collier A., Marra C.M., Ances B., Atkinson J.H., Dworkin R.H., Morgello S., Grant I. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. Arch. Neurol. 2010, 67:552-558.
19. Esiri M.M., Biddolph S.C., Morris C.S. Prevalence of Alzheimer plaques in AIDS. J.Neurol. Neurosurg. Psychiatry 1998, 65:29-33.
20. Ferreira A., Caceres A., Kosik K.S. Intraneuronal compartments of the amyloid precursor protein. J.Neurosci. 1993, 13:3112-3123.
21. Fischer R., Kohler K., Fotin-Mleczek M., Brock R. Astepwise dissection of the intracellular fate of cationic cell-penetrating peptides. J.Biol. Chem. 2004, 279:12625-12635.
22. Gelman B.B., Schuenke K. Brain aging in acquired immunodeficiency syndrome: increased ubiquitin-protein conjugate is correlated with decreased synaptic protein but not amyloid plaque accumulation. J.Neurovirol. 2004, 10:98-108.
23. Gelman B.B., Soukup V.M., Holzer C.E., Fabian R.H., Schuenke K.W., Keherly M.J., Richey F.J., Lahart C.J. Potential role for white matter lysosome expansion in HIV-associated dementia. J.Acquir. Immune Defic. Syndr. 2005, 39:422-425.
24. Giunta B., Hou H., Zhu Y., Rrapo E., Tian J., Takashi M., Commins D., Singer E., He J., Fernandez F., Tan J. HIV-1 Tat contributes to Alzheimer's disease-like pathology in PSAPP mice. Int. J. Clin. Exp. Pathol. 2009, 2:433-443.
25. Green D.A., Masliah E., Vinters H.V., Beizai P., Moore D.J., Achim C.L. Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS 2005, 19:407-411.
26. Harris J.R., Milton N.G. Cholesterol in Alzheimer's disease and other amyloidogenic disorders. Subcell Biochem 2010, 51:47-75.
27. Haughey N.J., Holden C.P., Nath A., Geiger J.D. Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein tat. J.Neurochem. 1999, 73:1363-1374.
28. Heaton R.K., Clifford D.B., Franklin D.R., Woods S.P., Ake C., Vaida F., Ellis R.J., Letendre S.L., Marcotte T.D., Atkinson J.H., Rivera-Mindt M., Vigil O.R., Taylor M.J., Collier A.C., Marra C.M., Gelman B.B., McArthur J.C., Morgello S., Simpson D.M., McCutchan J.A., Abramson I., Gamst A., Fennema-Notestine C., Jernigan T.L., Wong J., Grant I. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 2010, 75:2087-2096.
29. Henriques S.T., Melo M.N., Castanho M.A. Cell-penetrating peptides and antimicrobial peptides: how different are they?. Biochem. J. 2006, 399:1-7.
30. Hui L., Chen X., Haughey N.J., Geiger J.D. Role of endolysosomes in HIV-1 Tat-induced neurotoxicity. ASN Neuro. 2012, 4:243-252.
31. Jin L.W., Shie F.S., Maezawa I., Vincent I., Bird T. Intracellular accumulation of amyloidogenic fragments of amyloid-beta precursor protein in neurons with Niemann-Pick type C defects is associated with endosomal abnormalities. Am. J. Pathol. 2004, 164:975-985.
32. Kim T.A., Avraham H.K., Koh Y.H., Jiang S., Park I.W., Avraham S. HIV-1 Tat-mediated apoptosis in human brain microvascular endothelial cells. J.Immunol. 2003, 170:2629-2637.
33. King J.E., Eugenin E.A., Buckner C.M., Berman J.W. HIV Tat and neurotoxicity. Microbes Infect. 2006, 8:1347-1357.
34. Klug W., Dietl A., Simon B., Sinning I., Wild K. Phosphorylation of LRP1 regulates the interaction with Fe65. FEBS Lett. 2011, 585:3229-3235.
35. Koh Y.H., von Arnim C.A., Hyman B.T., Tanzi R.E., Tesco G. BACE is degraded via the lysosomal pathway. J.Biol. Chem. 2005, 280:32499-32504.
36. Liu Y., Jones M., Hingtgen C.M., Bu G., Laribee N., Tanzi R.E., Moir R.D., Nath A., He J.J. Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat. Med. 2000, 6:1380-1387.
37. Magzoub M., Pramanik A., Graslund A. Modeling the endosomal escape of cell-penetrating peptides: transmembrane pH gradient driven translocation across phospholipid bilayers. Biochemistry 2005, 44:14890-14897.
38. Marshansky V., Futai M. The V-type H+-ATPase in vesicular trafficking: targeting, regulation and function. Curr. Opin. Cell Biol. 2008, 20:415-426.
39. Merino J.J., Montes M.L., Blanco A., Bustos M.J., Oreja-Guevara C., Bayon C., Cuadrado A., Lubrini G., Cambron I., Munoz A., Cebolla S., Gutierrez-Fernandez M., Bernardino J.I., Arribas J.R., Fiala M. HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system (Neuropatogénesis inducida por el virus del sida: estrategias terapéuticas frente a la neurodegeneración inducida por la glucoproteína gp120/Tat en el sistema nervioso central). Rev. Neurol. 2011, 52:101-111. [in Spanish].
40. Nath A. Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J.Infect. Dis. 2002, 186(suppl 2):S193-S198.
41. Nath A., Haughey N.J., Jones M., Anderson C., Bell J.E., Geiger J.D. Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann. Neurol. 2000, 47:186-194.
42. Nath A., Psooy K., Martin C., Knudsen B., Magnuson D.S., Haughey N., Geiger J.D. Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J.Virol. 1996, 70:1475-1480.
43. Nebuloni M., Pellegrinelli A., Ferri A., Bonetto S., Boldorini R., Vago L., Grassi M.P., Costanzi G. Beta amyloid precursor protein and patterns of HIV p24 immunohistochemistry in different brain areas of AIDS patients. AIDS 2001, 15:571-575.
44. Nixon R.A., Cataldo A.M. The endosomal-lysosomal system of neurons: new roles. Trends Neurosci. 1995, 18:489-496.
45. Nixon R.A., Cataldo A.M. Lysosomal system pathways: genes to neurodegeneration in Alzheimer's disease. J.Alzheimers Dis. 2006, 9(3 suppl):277-289.
46. Nuovo G.J., Becker J., Burk M.W., Margiotta M., Fuhrer J., Steigbigel R.T. In situ detection of PCR-amplified HIV-1 nucleic acids in lymph nodes and peripheral blood in patients with asymptomatic HIV-1 infection and advanced-stage AIDS. J.Acquir. Immune Defic. Syndr. 1994, 7:916-923.
47. Perez A., Probert A.W., Wang K.K., Sharmeen L. Evaluation of HIV-1 Tat induced neurotoxicity in rat cortical cell culture. J.Neurovirol. 2001, 7:1-10.
48. Perez R.G., Soriano S., Hayes J.D., Ostaszewski B., Xia W., Selkoe D.J., Chen X., Stokin G.B., Koo E.H. Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42. J.Biol. Chem. 1999, 274:18851-18856.
49. Potocky T.B., Menon A.K., Gellman S.H. Cytoplasmic and nuclear delivery of a TAT-derived peptide and a beta-peptide after endocytic uptake into HeLa cells. J.Biol. Chem. 2003, 278:50188-50194.
50. Pulliam L. HIV regulation of amyloid beta production. J.Neuroimmune Pharmacol. 2009, 4:213-217.
51. Rajendran L., Schneider A., Schlechtingen G., Weidlich S., Ries J., Braxmeier T., Schwille P., Schulz J.B., Schroeder C., Simons M., Jennings G., Knolker H.J., Simons K. Efficient inhibition of the Alzheimer's disease beta-secretase by membrane targeting. Science 2008, 320:520-523.
52. Ravikumar B., Sarkar S., Davies J.E., Futter M., Garcia-Arencibia M., Green-Thompson Z.W., Jimenez-Sanchez M., Korolchuk V.I., Lichtenberg M., Luo S., Massey D.C., Menzies F.M., Moreau K., Narayanan U., Renna M., Siddiqi F.H., Underwood B.R., Winslow A.R., Rubinsztein D.C. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol. Rev. 2010, 90:1383-1435.
53. Rempel H.C., Pulliam L. HIV-1 Tat inhibits neprilysin and elevates amyloid beta. AIDS 2005, 19:127-135.
54. Sabatier J.M., Vives E., Mabrouk K., Benjouad A., Rochat H., Duval A., Hue B., Bahraoui E. Evidence for neurotoxic activity of Tat from human immunodeficiency virus type 1. J.Virol. 1991, 65:961-967.
55. Shimizu H., Tosaki A., Kaneko K., Hisano T., Sakurai T., Nukina N. Crystal structure of an active form of BACE1, an enzyme responsible for amyloid beta protein production. Mol. Cell. Biol. 2008, 28:3663-3671.
56. Soriano S., Chyung A.S., Chen X., Stokin G.B., Lee V.M., Koo E.H. Expression of beta-amyloid precursor protein-CD3gamma chimeras to demonstrate the selective generation of amyloid beta(1-40) and amyloid beta(1-42) peptides within secretory and endocytic compartments. J.Biol. Chem. 1999, 274:32295-32300.
57. Spector S.A., Zhou D. Autophagy: an overlooked mechanism of HIV-1 pathogenesis and neuroAIDS?. Autophagy 2008, 4:704-706.
58. Takahashi R.H., Milner T.A., Li F., Nam E.E., Edgar M.A., Yamaguchi H., Beal M.F., Xu H., Greengard P., Gouras G.K. Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am. J. Pathol. 2002, 161:1869-1879.
59. Tate B.A., Mathews P.M. Targeting the role of the endosome in the pathophysiology of Alzheimer's disease: a strategy for treatment. Sci. Aging Knowledge Environ. 2006, 2006:re2.
60. Van Broeck B., Vanhoutte G., Pirici D., Van Dam D., Wils H., Cuijt I., Vennekens K., Zabielski M., Michalik A., Theuns J., De Deyn P.P., Van der Linden A., Van Broeckhoven C., Kumar-Singh S. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease. Neurobiol. Aging 2008, 29:241-252.
61. Vassar R., Bennett B.D., Babu-Khan S., Kahn S., Mendiaz E.A., Denis P., Teplow D.B., Ross S., Amarante P., Loeloff R., Luo Y., Fisher S., Fuller J., Edenson S., Lile J., Jarosinski M.A., Biere A.L., Curran E., Burgess T., Louis J.C., Collins F., Treanor J., Rogers G., Citron M. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999, 286:735-741.
62. Vendeville A., Rayne F., Bonhoure A., Bettache N., Montcourrier P., Beaumelle B. HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses. Mol. Biol. Cell 2004, 15:2347-2360.
63. Vives E., Brodin P., Lebleu B. Atruncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J.Biol. Chem. 1997, 272:16010-16017.
64. Waldron E., Heilig C., Schweitzer A., Nadella N., Jaeger S., Martin A.M., Weggen S., Brix K., Pietrzik C.U. LRP1 modulates APP trafficking along early compartments of the secretory pathway. Neurobiol. Dis. 2008, 31:188-197.
65. Waldron E., Jaeger S., Pietrzik C.U. Functional role of the low-density lipoprotein receptor-related protein in Alzheimer's disease. Neurodegener. Dis. 2006, 3:233-238.
66. Weeks B.S., Lieberman D.M., Johnson B., Roque E., Green M., Loewenstein P., Oldfield E.H., Kleinman H.K. Neurotoxicity of the human immunodeficiency virus type 1 tat transactivator to PC12 cells requires the Tat amino acid 49-58 basic domain. J.Neurosci. Res. 1995, 42:34-40.
67. Westendorp M.O., Frank R., Ochsenbauer C., Stricker K., Dhein J., Walczak H., Debatin K.M., Krammer P.H. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 1995, 375:497-500.
68. Williamson W.R., Wang D., Haberman A.S., Hiesinger P.R. Adual function of V0-ATPase a1 provides an endolysosomal degradation mechanism in Drosophila melanogaster photoreceptors. J.Cell Biol. 2010, 189:885-899.
69. Wong E., Cuervo A.M. Autophagy gone awry in neurodegenerative diseases. Nat. Neurosci. 2010, 13:805-811.
70. Xiao H., Neuveut C., Tiffany H.L., Benkirane M., Rich E.A., Murphy P.M., Jeang K.T. Selective CXCR4 antagonism by Tat: implications for invivo expansion of coreceptor use by HIV-1. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:11466-11471.
71. Xu J., Ikezu T. The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART era. J.Neuroimmune Pharmacol. 2009, 4:200-212.
72. Zhou D., Spector S.A. Human immunodeficiency virus type-1 infection inhibits autophagy. AIDS 2008, 22:695-699.